Pulmonary infections with Burkholderia cepacia complex organisms contribute significantly to morbidity and mortality in patients with cystic fibrosis (CF), partially due to the intense inflammatory response of the host to the presence of bacteria and their byproducts. In the present study we show that Burkholderia genomes contain a large number of immunostimulatory CpG motifs. This is mainly because of their large genome size. This suggests that DNA from Burkholderia sp. has the potential to cause significant inflammatory response. Whether this contributes significantly to the airway inflammation often observed in infected CF patients remains to be determined.
Introduction
In persons with cystic fibrosis (CF), pulmonary disease is the major cause of morbidity and mortality; mutations in the cftr gene result in an altered airway surface liquid (ASL) which in some way predisposes the lungs to bacterial infections [1] . Organisms typically associated with the respiratory tract of CF patients are Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa and Burkholderia cepacia complex bacteria [2] . Due to the high viscosity of respiratory secretions and the altered ASL, normal host defense mechanisms are impaired and despite the intense inflammatory response, the host does not have the ability to clear the infection [3] . The continuous presence of bacteria and their byproducts in the lungs of CF patients leads to a vicious cycle in which the host immune response leads to more tissue damage, leading to more infection and further inflammation [4] . There are strong indications that the inflammatory response to P. aeruginosa infection is induced by lipopysaccharide (LPS), phospholipase C and exotoxin A [5] [6] [7] . Similarly, several studies have shown that LPS from B. cepacia complex bacteria can activate neutrophils [8] and stimulate tumor necrosis factor a production [9, 10] . There are also indications that during infections with Burkholderia pseudomallei and Burkholderia mallei (the causative agents of melioidosis and glanders, respectively) an intense inflammatory response is mounted (see for example Refs. [11, 12] ).
It has been known for over 20 years that bacterial DNA can activate the human immune system [13 -15] . Several studies in the early 1990s showed that the immunostimulatory properties of bacterial DNA could be attributed to the presence of unmethylated CpG dinucleotides [16] [17] [18] . Bacterial DNA can induce B-cells to proliferate and secrete immunoglobulines [19] , can induce the production of immunomodulatory cytokines [20] , can activate the acute phase response [21] and can activate specific subsets of dendritic cells [22] . It is thought that the response to CpG motifs is mediated by the Toll-like receptor 9 (TLR9) [23 -25] and differences in human and murine TLR9 specificity might explain why the immune system of both organisms is stimulated by different CpG-containing motifs [25 -27] . Several studies have indicated that TLR9 mediates the immune response in a concentration-dependent way, i.e. DNA molecules containing multiple CpG motifs have a greater stimulatory capacity [28, 29] . In addition, it has been suggested that the immunomodulatory effects of DNA may augment the inflammatory response to endotoxin, indicating that the presence of bacterial DNA might increase the sensitivity to toxic effects of LPS. In contrast to bacterial DNA, vertebrate DNA shows a significant CpG suppression [30, 31] and it has been postulated that the vertebrate immune system has evolved to recognise unmethylated CpG motifs and can respond to them with a rapid and coordinated cytokine response, leading to induction of humoral and cell-mediated immunity.
In the present study we compared the occurrence of CpG-containing motifs in the Burkholderia cenocepacia strain J2315 genome with the occurrences in other bacterial genomes, including those of other CF pathogens and other Burkholderia species.
Materials and methods
Complete genome sequences used in the present study are shown in Table 1 . We included all completely sequenced Burkholderia genomes, as well as large contigs of other Burkholderia genomes. For comparison we also included (i) genome sequences of other CF pathogens and (ii) genome sequences of other organisms with a comparable GC content and/or genome size. To determine the dinucleotide relative abundance and absolute number and frequencies of CpG-containing motifs of different lengths, sequences were first concatenated with their inverted complementary sequence using the EMBOSS package (http://www.hgmp.mrc.ac.uk/software/EMBOSS). Dinucleotide relative abundances q* XY were calculated using the equation q* XY = f XY / f X f Y where f XY denotes the frequency of dinucleotide XY and f X and f Y denote the frequencies of X and Y, respectively [32] . Statistical theory and data from previous studies [31, 32] indicate that the normal range of q* XY is between 0.78 and 1.23. Absolute number and frequencies of the CpG-containing motifs 5V -GTCGTT-3V and 5V -GACGTT-3V (considered to be the most stimulatory for human and murine cells, respectively [24, 27] ) were determined using compseq (EMBOSS). For strains R-18194, R-1808 and LB400 T , we extrapolated the absolute number of CpG containing motifs based on the numbers observed in the contigs listed in Table 1 and the estimated total genome size. Statistical analyses were performed using the SPSS 11.0.1 software package (SPSS Inc., Chicago, IL).
Results and discussion
GC content, CpG dinucleotide relative abundance and absolute number and frequencies of CpG-containing motifs are shown in Table 1 . The q* CG values of all Burkholderia genomes were significantly higher than those of the other genomes ( P < 0.001). The total number of CpG motifs ranged from 145,046 (H. influenzae) to 2,819,378 (B. cepacia complex R-18194). The lowest density of CpG motifs was found in the S. aureus genome (2.55%), while this density was highest in B. mallei ATCC 23344 (18.19%). The motif GTCGTT was most abundant in B. cepacia complex R-18194 (6232), while this motif was only encountered 677 times in the H. influenzae genome. The same trend was observed for the GACGTT motif, which was most abundant in B. cepacia complex R-18194 (5221), while this motif was only encountered 532 times in the H. influenzae genome. The density of the GTCGTT motif was also highest in B. cepacia complex R-18194 (0.03623%), while the C. violaceum genome had the lowest density for this motif (0.01285%). The highest GACGTT motif density was found in B. vietnamiensis (0.03403%), while the lowest density was found in the B. pertussis genome (0.01401%). Not unexpectedly, there is an almost perfect linear correlation between genome size and number of CpG motifs, GTCGTT motifs and GACGTT motifs (r 2 = 0.925, r 2 = 0.932 and r 2 = 0.919, respectively) ( P < 0.01 for all correlations) (Fig. 1) . However, there is no correlation between genome size and motif density (Fig. 1) . There is also a significant (but non-linear) relationship between GC content and the absolute number of the various CpG motifs (data not shown), as genomes with a higher GC content tend to have more of these repeats. However, when controlling for the effect of genome size (as larger genomes also tend to be more GC-rich), this correlation is not significant. When we compared the absolute number and frequency of CpG motifs, we found that the absolute number of CpG motifs is significantly higher in Burkholderia genomes than in non-Burkholderia genomes ( P < 0.001). The absolute number of GTCGTT and GACGTT motifs is also significantly higher in Burkholderia genomes than in non-Burkholderia genomes ( P < 0.01 for both motifs). In contrast to the absolute numbers, the differences in frequency are not statistically significant (data not shown).
Data from the present study show that Burkholderia genomes contain a large number of immunostimulatory CpG motifs and our statistical analyses indicate that this is mainly due to their large size. This suggests that DNA from Burkholderia sp. has the potential to cause significant inflammatory response. Whether this contributes significantly to the airway inflammation often observed in infected CF patients (either directly or by increasing the sensitivity to toxic effects of LPS and/or other bacterial products) remains to be determined. 
